Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

MSTA
Your future
starts here.

Lactic acid

Also known as: lactic acid, AHA, alpha-hydroxy acid, ammonium lactate

Lactic acid is an alpha-hydroxy acid used at 5–12% in cosmetic products and from 10% to 92% as a professional peel. Lactate is also a genuine component of natural moisturising factor — which is a separate fact from what a free-acid peel does.

Evidence status

Moderate

The evidence splits three ways and practitioners should not treat it as one body. (1) Melasma: genuinely moderate — multiple randomised comparative trials plus a 2024 systematic review exist, but the findings are not flattering to lactic acid. The only randomised head-to-head against glycolic acid found glycolic significantly SUPERIOR (median MASI fall 2.85 vs 1.8, P=0.009), and the 2024 systematic review of 24 studies (n=1,075) concluded glycolic acid was the most safe and effective peel in melasma. Nearly all lactic acid melasma trials are small, single-centre, from India or Iraq, in Fitzpatrick III-V, with short follow-up. (2) Hydration/barrier: mechanistically coherent but manufacturer-dominated — the two foundational papers are authored entirely by Unilever Research and Kanebo Cosmetics staff respectively. (3) Penetration: the 'larger molecule, shallower penetration than glycolic' rationale is a physicochemical inference. No head-to-head penetration or peel-depth study comparing lactic and glycolic acid was found, and the principal hydroxy-acid review does not discuss molecular weight as a determinant of AHA penetration at all.

What it is#

Lactic acid is an alpha-hydroxy acid — molecular weight 90.08 g/mol against glycolic acid’s 76.05, a difference of a single CH2 group, and marginally less hydrophilic.[2]

It occupies a peculiar position in professional teaching: almost everything said about it is plausible, widely repeated, and either unmeasured or contradicted by the one trial that tested it. This entry goes through those claims one at a time — and keeps the genuinely good findings, because there are several.

The size story#

“Lactic acid is a larger molecule than glycolic, so it does not penetrate as deeply, so it is gentler.” Every course teaches it.

We could not find a study that measured it. No comparison of skin penetration depth, stratum corneum uptake or histological peel depth between lactic and glycolic acid at matched concentration or pH.[no source found]

More telling: the principal review of hydroxy-acid mechanisms does not discuss molecular weight as a determinant of AHA penetration at all, and offers no glycolic-versus-lactic comparison. The only penetration mechanism it addresses is lipophilicity — and that for a beta-hydroxy acid derivative.[15]

The molecular weights are real. The inference from them is a mechanistic story that has hardened into a fact through repetition. It may well be right; we found no head-to-head human comparison in the search performed for this entry.

Concentrations#

A genuine trap, because two completely different treatments share a name.

Standard teaching references classify 10–30% as a light peel. The published melasma trials use 80%, 90% and 92% — with the original protocol specifying pure lactic acid at 92% and pH 3.5.[1, 3, 5, 6]

So when someone cites “the evidence for lactic acid in melasma” while performing a 20% peel, they are quoting a different procedure. A 92% free-acid peel at pH 3.5 is a keratocoagulant intervention, not a gentle exfoliation.

The NMF question#

Here the story is better than the sceptic expects — and it still does not support what it is used to support.

Lactate is a genuine, measurable component of natural moisturising factor in human stratum corneum, not merely a marketing description. It is significantly depleted in mild atopic dermatitis skin, alongside PCA, urea, sodium and potassium.[10]

And a detail worth correcting your own teaching on: stratum corneum lactate is concentrated in the surface layers and is largely supplied from outside the corneocyte — from sweat — unlike filaggrin-derived free amino acids and PCA. NMF is not simply a filaggrin breakdown product.[10]

There is partial human support for the humectant claim: topical potassium lactate was the only depleted NMF component that measurably increased skin surface hydration when reapplied in atopic dermatitis skin.[10]

Where it stops

In a vehicle-controlled, randomised-order, within-subject study on the forearms of 20 healthy subjects, 5% urea and both urea/ammonium-lactate combinations produced significant stratum corneum hydration and improved barrier function, with no significant difference between the three. 5% ammonium lactate alone was not among the treatments reported to achieve either.[11]

Be careful how you read that. The authors do not state that it failed — it is an absence in the reported results rather than a demonstrated negative. And the agent was ammonium lactate, the neutralised salt, not free lactic acid.

None of the NMF evidence has any bearing on a 92% peel. It concerns lactate at physiological levels and neutralised salts in leave-on products.

The isomer finding#

The most interesting thing in this entry, and almost nobody teaches it.

Lactic acid raises stratum corneum ceramide levels in living human skin and improves barrier function — and the effect is isomer-specific. L-lactic acid produced a 48% rise in stratum corneum ceramides; D,L-lactic acid 25%; and D-lactic acid no effect at all. Barrier improvement and resistance to xerosis followed L- and D,L- but not D-.[9]

If that holds, the isomer on the label is a more meaningful variable than the percentage — and it is one almost no professional product discloses.

The proposed mechanism — that lactic acid stimulates keratinocyte ceramide biosynthesis, with L- producing a 300% increase against 100% for D- — rests on in-vitro keratinocyte work. Treat it as a proposed explanation rather than a demonstrated in-vivo pathway.[9]i

Melasma#

The indication lactic acid is most often chosen for, and the one where the evidence is least flattering.

The original evidence is open-label and uncontrolled: 20 patients enrolled, only 12 completing, all Fitzpatrick IV with epidermal melasma, treated with 92% lactic acid at pH 3.5 every three weeks for up to six sessions. Statistically significant MASI improvement, no side effects recorded.[3]

Against Jessner’s solution it held its own: in a 30-patient split-face comparison (24 completing), 92% lactic acid was as effective as Jessner’s on the other side, both with significant MASI improvement and no side effects — though side allocation was fixed rather than randomised and no blinding was described.[4]

Against pyruvic acid it was slightly but not significantly better: mean MASI fell 55.4% versus 52.1%, both peels safe with only mild burning — though both arms were primed with 0.025% tretinoin for two weeks beforehand.[6]

Against glycolic acid, it lost

In the only randomised head-to-head found, 50% glycolic acid significantly outperformed 80% lactic acid: median MASI reduction 2.85 versus 1.8, P = 0.009, across four sessions at two-week intervals in Fitzpatrick III–V patients.[5]

And a 2024 systematic review of 24 studies and 1,075 patients concluded that glycolic acid was the most safe and effective peeling agent in melasma — though heterogeneity prevented meta-analysis, so that ranking is a qualitative judgement rather than a pooled estimate.[13]

There may also be a direct pigment action: lactic acid inhibits tyrosinase independently of its acidity. But that was shown only in mouse and human melanoma cell lines, and glycolic acid inhibited melanin formation in a similar dose-dependent way — so it offers no basis for preferring lactic acid.[12]i

Is it gentler?#

The claim the whole positioning rests on. The honest answer is “probably, and nobody has shown it”.

In the head-to-head trial, 4 of 18 glycolic acid patients had adverse effects — two erythema, one frosting, one post-inflammatory hyperpigmentation — versus 0 of 16 in the lactic acid arm. But the difference was not statistically significant (P = 0.105), and the trial was underpowered for safety.[5]

There is a real counterweight in its favour, at strengths you would actually use. In a 70-patient randomised comparison in periorbital melanosis, 30% lactic acid produced significantly greater pigment reduction than 30% mandelic acid (P = 0.001) with higher patient satisfaction (100% versus 83.9%, P = 0.011), irritation more frequent in the mandelic arm, and the authors concluding lactic acid may suit sensitive skin.[7]

So the tolerability story is not empty — it is just not established against the comparator everyone invokes.

Photoageing#

One useful finding, from evidence weaker than its citation count implies.

In one 1996 study, 12% lactic acid twice daily for three months was associated with epidermal and dermal changes — firmness and thickness, with clinical improvement in smoothness, lines and wrinkles — whereas 5% was associated with surface and epidermal changes only.[8]

Do not treat that as an actionable threshold, which is how this page previously read. The accessible record gives no sample size, no randomisation or blinding, no vehicle or untreated arm and no numerical effect sizes — a two-concentration comparison on that basis cannot establish a clinical cut-off. The report does not state the number of subjects, does not describe randomisation, blinding or a vehicle-controlled arm, and gives no numerical effect sizes. It compares 5% against 12%, not against untreated skin.[8]

Darker skin#

Lactic acid is widely promoted as the peel of choice for higher phototypes. The evidence for that is thinner than the promotion.

It does not appear in any pooled comparison in the one meta-analysis dedicated to chemical peels for melasma in dark-skinned patients — 13 studies, 478 patients.[14]

What evidence exists is narrow: the melasma trials were conducted almost entirely in Fitzpatrick III–V populations in Iraq and India. The foundational study was restricted to skin type IV with epidermal melasma confirmed on Wood’s light in every patient; the split-face study describes its patients only as “mostly” type IV with “mostly” epidermal melasma.[3, 4, 5]

On sun sensitivity we found no lactic-acid study in our search.[no source found] The photosensitising finding is for glycolicacid at 10%, in 14 subjects of Fitzpatrick II–III, described by its own authors as a small effect — and the same review notes that all such studies were done in types I–III and that cohorts of IV–VI are still needed.[15]

Sun-protection advice after a lactic acid peel is therefore extrapolated, not evidenced. Give it anyway — but know which it is.

Inside Jessner's#

Jessner’s solution contains 14% lactic acid, alongside 14% resorcinol and 14% salicylic acid, in ethanol.[1]

Which means its clinical results cannot be attributed to the lactic acid— including its superiority over hydroquinone in melasma in darker skin (mean MASI difference −3.20, 95% CI −5.35 to −1.05, P = 0.004).[1, 14]i

If you have been citing Jessner’s data as evidence for lactic acid, that is a three-ingredient formulation being credited to one component.

UK regulation#

No licensing scheme for non-surgical cosmetic procedures is in force in England. The green/amber/red three-tier model remains a proposal requiring secondary legislation, and the consultation response of 7 August 2025 explicitly states that further work is required to determine where specific procedures will sit.[16]

One proposal detail is directly relevant here: chemical peels were proposed to “sit across different categories” according to strength and depth of penetration — so a 10–30% lactic acid peel and a 92% lactic acid peel could in principle fall into different tiers. No such assignment has been made.[16]i

In voluntary regulation, lactic acid peels sit under the JCCP/CPSA modality “Skin Rejuvenation — Micro Needling and Peels”, one of five recognised modalities. JCCP registration carries no legal force.[17]

In professional practice#

  • Stop saying “gentler because it is a bigger molecule”. Nobody has measured the penetration difference, and the tolerability difference was not significant.
  • Know which lactic acid you mean. A 20% peel and a 92% peel share a name and nothing else.
  • Ask your supplier which isomer — on the strength of one 1996 lotion study, not a peel comparison. L- raised ceramides 48%; D- did nothing. It is the variable nobody discloses.
  • If the goal is melasma, glycolic has the better evidence — from one small trial comparing non-equivalent strengths, 50% glycolic against 80% lactic, with no significant tolerability difference, and a heterogeneous 2024 synthesis that favoured glycolic qualitatively without being able to pool anything. That is not a universal treatment rule.
  • Do not cite Jessner’s results as lactic acid results. Three actives, one credit.
  • 12% is where dermal change was reported in one poorly specified 1996 study — not a validated threshold. Dermal change was reported; 5% gave epidermal change only.
  • Give sun-protection advice anyway, while knowing it is extrapolated from glycolic acid data in lighter phototypes.

What remains uncertain#

  • Whether lactic acid penetrates less deeply than glycolic acid at all. No comparative study was found in our search.
  • Whether it is genuinely gentler. Directionally supported, not statistically shown, in an underpowered trial.
  • Whether the isomer effect on ceramides translates into clinical benefit from a peel, as opposed to a leave-on product.
  • Anything specific to Fitzpatrick V–VI. The published work is concentrated in III–V, and lactic acid is absent from the dark-skin meta-analysis.
  • Photosensitivity after lactic acid, for which we found no study.
  • The photoageing evidence base, where the key paper’s sample size, control arm and blinding could not be verified.

Common misconceptions#

“It’s gentler than glycolic.”

Directionally supported and not statistically demonstrated — 4/18 adverse events versus 0/16, P = 0.105, in a trial the authors flagged as small.[5]

“It’s the better melasma peel.”

The only randomised head-to-head found the opposite, and a 2024 systematic review named glycolic acid the most safe and effective agent in melasma.[5]

“Bigger molecule, shallower penetration.”

The molecular weights are real; the inference is unmeasured, and the principal mechanism review does not discuss molecular weight as a penetration determinant at all.[15]

“It’s a humectant, so it hydrates.”

The NMF role is real, but 5% ammonium lactate alone was not among the treatments that achieved significant hydration where urea did — and none of that applies to a free-acid peel.[11]

“Jessner’s is a lactic acid peel.”

It contains 14% lactic acid but equally 14% salicylic acid and 14% resorcinol. Its effects cannot be attributed to one component.[1, 14]i

“It’s the safe choice for darker skin.”

It does not appear in any pooled comparison in the meta-analysis dedicated to peels in dark-skinned patients.[14]

Frequently asked questions#

Should I choose lactic or glycolic for a melasma client?

The evidence leans glycolic and it is thinner than that sentence makes it sound. One small head-to-head trial found greater MASI reduction with 50% glycolic than 80% lactic — non-equivalent strengths — without a significant tolerability difference. A heterogeneous 2024 synthesis favoured glycolic qualitatively but could not pool the data.[13]

That does not settle a universal choice. Use the melasma entry for assessment and the chemical-peel entry for procedural safety, and decide on the client in front of you rather than on a ranking the evidence cannot support.

Does the isomer really matter?

On one 1996 Unilever-authored lotion study of unreported size and concentration, substantially: 48% ceramide increase with L-, none with D-. Worth asking your supplier, and worth noting almost none of them say.[9]

Why do the studies use 92% when I was taught 10–30%?

Because they are different procedures. 10–30% is a light peel in standard references; the melasma literature used 80–92% at pH 3.5. Do not borrow one’s evidence for the other.[1, 3, 5, 6]

Is it safe in pregnancy or on sensitive skin?

On sensitive skin there is one supportive randomised comparison, where 30% lactic acid was both more effective and better tolerated than 30% mandelic acid. That is the strongest tolerability evidence in the entry.[7]

What sun advice do I give afterwards?

The same as for any AHA — while knowing it is extrapolated. The photosensitivity data are for 10% glycolic acid in Fitzpatrick II–III; no lactic acid study exists.[15]

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. Samargandy S, Raggio BS. Chemical Peels for Skin Resurfacing. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; last updated 29 October 2023. Bookshelf ID NBK547752.Tier 4Supports: Source of the Jessner's solution formula, verbatim: "This solution is a mixture of 14% resorcinol, 14% salicylic acid, and 14% lactic acid dissolved in ethanol." Also classifies lactic acid as an alpha hydroxy acid derived from milk, describes it as a keratolytic available in concentrations of 10% to 30%, and places "10% to 30% lactic acid" in the light (superficial) peel category. SCOPE LIMIT: this is a tertiary teaching reference, not primary data. It does NOT specify lactic acid's penetration depth relative to other AHAs and provides NO targeted guidance on lactic acid in Fitzpatrick III-VI; it only recommends general caution with all peeling agents in darker skin because of dyschromia risk.Funding / interest: No commercial funding declared; StatPearls is a subscription medical education publisher.
  2. PubChem Compound Summary. Lactic acid, CID 612; Glycolic acid, CID 757. National Center for Biotechnology Information, US National Library of Medicine. Accessed 1 August 2026.Tier 4Supports: Retrieved directly from the PubChem REST API. Lactic acid: CID 612, molecular formula C3H6O3, molecular weight 90.08 g/mol, IUPAC name 2-hydroxypropanoic acid, XLogP -0.7. Glycolic acid: CID 757, molecular formula C2H4O3, molecular weight 76.05 g/mol, IUPAC name 2-hydroxyacetic acid, XLogP -1.1. This establishes that lactic acid is the larger molecule (90.08 vs 76.05 g/mol, a difference of one CH2 group) and is marginally less hydrophilic (XLogP -0.7 vs -1.1). SCOPE LIMIT: this is physicochemical reference data only. It says NOTHING about skin penetration depth, clinical potency or tolerability, and cannot on its own support any penetration claim.
  3. Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg. 2005 Feb;31(2):149-54; discussion 154. PMID 15762205.Tier 3Supports: The original lactic acid melasma study. Open-label, uncontrolled, single-arm case series at Baghdad Teaching Hospital, April 2001-August 2002. Twenty patients enrolled (18 female, 2 male; age 24-38, mean 29 +/- 4.264 SD). Agent: "Pure lactic acid, full strength (92%; pH 3.5)". Sessions every 3 weeks until desired response, maximum six sessions; follow-up 6 months after last session. Assessment by Melasma Area Severity Index (MASI) and Wood's light. ALL patients were skin type IV. Morphology: mask-like 7 (35%), butterfly 9 (45%), horseshoe 4 (20%). RESULTS: "Eight patients defaulted from the study after the first session for unknown reasons" — only 12 of 20 completed (40% attrition). Sessions ranged two to six. Wood's light showed increased contrast in all, i.e. epidermal melasma. "All 12 patients showed marked improvement, as calculated by the MASI score before and after treatment, and the response was highly statistically significant. No side effect was recorded in all treated patients." SCOPE LIMITS: no control arm, no randomisation, no blinding, 40% dropout, single skin type (IV only), epidermal melasma only, and the abstract reports NO numerical MASI values or percentage reduction.Funding / interest: No funding or conflict statement in the PubMed record. University of Baghdad academic authors; no declared commercial interest.
  4. Sharquie KE, Al-Tikreety MM, Al-Mashhadani SA. Lactic acid chemical peels as a new therapeutic modality in melasma in comparison to Jessner's solution chemical peels. Dermatol Surg. 2006 Dec;32(12):1429-36. PMID 17199649.Tier 3Supports: Split-face comparative study, same Baghdad centre and same period (April 2001-August 2002). Thirty patients enrolled, "mostly of skin type IV according to Fitzpatrick's classification", 26 women (86.67%), 4 men (13.33%), age 18-50 (mean +/- SD 33.53 +/- 6.96 years). Design: "Pure lactic acid full strength (92%, pH 3.5) was used as a new peeling agent on the left side of the face while Jessner's solution was applied to the right side of the face." Sessions every 3 weeks until desired response; 6-month follow-up. RESULTS: six defaulted after the first session; 24 completed. Number of sessions 2 to 5. Wood's light showed mostly epidermal melasma. "All patients showed marked improvement as calculated by MASI score before and after treatment, and the response was highly statistically significant. No side effect was recorded in all treated patients." CONCLUSION verbatim: lactic acid "was as effective as Jessner's solution." SCOPE LIMITS: side allocation to left/right was fixed rather than randomised, no blinding stated, 20% dropout, predominantly skin type IV, epidermal melasma, and again NO numerical MASI values in the abstract. Note the important internal comparison: this is lactic acid 92% versus a solution that itself contains 14% lactic acid alongside 14% salicylic acid and 14% resorcinol.Funding / interest: No funding or conflict statement in the PubMed record. University of Baghdad academic authors.
  5. Kadu PP, Laul RA. 80% Lactic Acid Peel Versus 50% Glycolic Acid Peel for Melasma: A Randomised Clinical Trial. Indian J Dermatol. 2025 May-Jun;70(3):152-156. PMID 40487492; PMCID PMC12139622.Tier 2Supports: THE MOST DIRECTLY DECISIVE SOURCE for the lactic-versus-glycolic question. Prospective, single-blinded (study subjects), randomised trial, Government Medical College, Akola, Central India. Forty patients aged 18-50 randomised 20/20 to 80% lactic acid or 50% glycolic acid, four sessions at 2-week intervals; MASI at baseline and 10 weeks; Mann-Whitney test. Thirty-four completed (18 glycolic, 16 lactic); six lost to follow-up. "All the patients belonged to Fitzpatrick skin phototypes III, IV, and V." EFFICACY: median (25th-75th percentile) MASI decrease with glycolic 50% was 2.85 (1.875-3) versus lactic 80% at 1.8 (1.125-2.4), P = 0.009 — glycolic SIGNIFICANTLY SUPERIOR. MASI values: glycolic baseline 8.2 (6-12.6) to 5.4 (3.6-9.6); lactic baseline 8.65 (5.325-14.025) to 7.1 (3.6-11.4). TOLERABILITY (the crux of the 'gentler' claim): glycolic arm 4 of 18 had adverse effects — 2 erythema, 1 frosting, 1 post-inflammatory hyperpigmentation; lactic arm 0 of 16 reported any adverse effect. BUT: "The difference between the side effects, however, was not statistically significant (P value 0.105)." Authors' conclusion: "50% glycolic acid peel is more efficacious than 80% lactic acid peel for the treatment of melasma." STATED LIMITATIONS: small sample size; failure to evaluate melasma depth (epidermal, dermal or mixed) or relate efficacy to lesion depth. Also note the concentrations are not equipotent — 80% lactic versus 50% glycolic is not a like-for-like molar comparison.Funding / interest: "Funding Statement: Nil" and "There are no conflicts of interest."
  6. Goyal S, Brar BK, Kumar S, Boparai A, Hundal S, Mehta A. Comparative Evaluation of Therapeutic Efficacy and Safety of 90% Lactic Acid Peel Versus 40% Pyruvic Acid Peel in Epidermal Melasma. Indian Dermatol Online J. 2025 Jun 17;16(4):564-570. PMID 40688117; PMCID PMC12270427.Tier 2Supports: Randomised comparative trial, Guru Gobind Singh Medical College, Faridkot, Punjab. Sixty patients randomised to two groups of 30. IMPORTANT PRACTICE DETAIL: "Priming was done by 0.025% tretinoin cream daily for 2 weeks prior to the peeling" — the lactic acid arm was primed, not peeled cold. Group A: 90% lactic acid every 2 weeks; Group B: 40% pyruvic acid every 2 weeks, for 12 weeks. Mean age 33.57 (A) and 33.36 (B). Centrofacial pattern in 56.7% (A) and 63.33% (B). RESULTS: mean MASI fell 10.42 to 4.59 in the lactic arm and 9.65 to 4.53 in the pyruvic arm; at 24 weeks percentage reduction was 55.44% (lactic) versus 52.07% (pyruvic). MELASQoL fell from 36.83 to 21.30 (lactic) and 37.70 to 20.10 (pyruvic). CONCLUSION verbatim: "lactic acid 90% peel showed slightly better results compared to pyruvic acid 40% peel, though not statistically significant. Both peels were safe. Mild burning sensation was reported by a few patients." SCOPE LIMITS: authors state "Small sample size"; epidermal melasma only; no glycolic acid comparator; no untreated or vehicle control, so the tretinoin priming and natural history cannot be separated from the peel effect. Fitzpatrick types not reported in the abstract, though the Punjab population is predominantly III-V.Funding / interest: "There are no conflicts of interest."
  7. Malviya A, Shrivastava S, Pancholi S, Hassanandani T, Kumar V, Dhakad JS. A Prospective Study Comparing Clinical Efficacy of 30% Mandelic Acid Peel Versus 30% Lactic Acid Peel in Periorbital Melanosis. Indian Dermatol Online J. 2025 Nov 1;16(6):916-920. PMID 41051381; PMCID PMC12622926.Tier 2Supports: Included for BALANCE — this is the trial where lactic acid wins, and at a realistic professional concentration rather than 80-92%. Prospective comparative study, tertiary institute, 18 months (September 2022-February 2024), 70 patients randomly assigned to 30% mandelic acid (35) or 30% lactic acid (35), three sessions at weeks 0, 2 and 4, end-of-study visit week 6. Outcomes: periorbital melanosis grading, visual analogue scale, patient satisfaction, adverse events. RESULTS: both improved significantly, but "the lactic acid group exhibited a significantly greater reduction in pigmentation (50% of patients with more than 30% improvement in VAS, P = 0.001)". Patient satisfaction 100% (lactic) versus 83.9% (mandelic), P = 0.011. Side effects were mild erythema and swelling in both, with "exfoliation more common in the lactic acid group and irritation more frequent in the mandelic acid group". Authors conclude "lactic acid may be better for sensitive skin due to milder side effects". SCOPE LIMITS: the indication is periorbital melanosis (dark circles), NOT melasma — do not transfer the result. Authors state the study "is limited by its small sample size and short duration, which may impact the generalizability and long-term evaluation of the treatments". The comparator is mandelic acid, not glycolic acid, so this does not resolve the lactic-versus-glycolic gentleness question.Funding / interest: "There are no conflicts of interest."
  8. Smith WP. Epidermal and dermal effects of topical lactic acid. J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):388-91. PMID 8784274.Tier 3Supports: The most-cited source for lactic acid in photoageing, and the origin of the 5%-versus-12% distinction used throughout cosmetic practice. Participants applied either 5% or 12% lactic acid twice a day for 3 months. Outcomes measured: skin smoothness and texture, depth and number of lines and wrinkles, and epidermal and dermal firmness and thickness. RESULTS verbatim: "Treatment with 12% lactic acid resulted in increased epidermal and dermal firmness and thickness and clinical improvement in skin smoothness and in the appearance of lines and wrinkles. No dermal changes were observed after treatment with 5% lactic acid; however, similar clinical and epidermal changes were noted." Conclusion: "Although 5% lactic acid modulates surface and epidermal changes, 12% lactic acid influences both the epidermis and the dermis." IMPORTANT SCOPE LIMITS, stated honestly: the abstract does NOT report the number of subjects, does not describe randomisation or blinding, and does not describe a vehicle or placebo control arm — the comparison is 5% against 12%, not against untreated skin. No numerical effect sizes are given for any outcome. I attempted to retrieve the full text via the publisher and received HTTP 403, so these design details could not be verified beyond the abstract. Treat the dose-response conclusion as suggestive rather than established.Funding / interest: No affiliation, funding or conflict-of-interest statement appears in the PubMed record, and the full text was not accessible to verify. Single-author paper. Commercial sponsorship can neither be confirmed nor excluded — a genuine gap, noted because much AHA cosmetic-efficacy work of this era was industry-conducted.
  9. Rawlings AV, Davies A, Carlomusto M, Pillai S, Zhang K, Kosturko R, Verdejo P, Feinberg C, Nguyen L, Chandar P. Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res. 1996 Jun;288(7):383-90. PMID 8818186.Tier 3Supports: The mechanistic basis for the barrier/moisturisation claim, combining in-vitro and in-vivo human work — the two must not be conflated. IN VITRO: "lactic acid enhanced the production of ceramides by keratinocytes. L-Lactic acid was more effective than the D isomer (300% increase vs 100% increase)." Carbon label from lactic acid was incorporated into all keratinocyte lipid species, with greater incorporation into ceramides from L-lactate. IN VIVO (human): lotions containing L-lactic acid produced the greatest rise in stratum corneum ceramides (48% increase), followed by D,L-lactic acid (25% increase), while "D-lactic acid had no effect on stratum corneum ceramide levels." These ceramide increases "led to improvements in stratum corneum barrier function, measured by transepidermal water loss following a challenge to the skin with SLS and in the regression phase of a moisturization efficacy study. Significant improvements in barrier function and resistance to the appearance of skin xerosis were observed following L-lactic acid and D,L-lactic acid, but not following D-lactic acid treatment." PRACTICE-RELEVANT: isomer identity matters, and most cosmetic lactic acid is racemic D,L, which performed at roughly half the ceramide effect of pure L. SCOPE LIMITS: leave-on lotion concentrations, not peel concentrations; xerosis/barrier endpoints, not photoageing or pigmentation; sample sizes and lotion concentrations not given in the abstract; no comparison against glycolic acid.Funding / interest: MAJOR COMMERCIAL INTEREST: all ten authors are affiliated to Unilever Research, Edgewater Laboratory, NJ. Unilever manufactures and markets lactic-acid-containing moisturisers, and the paper's conclusion directly supports a product claim (L-lactic acid superiority). Weight accordingly.
  10. Sugawara T, Kikuchi K, Tagami H, Aiba S, Sakai S. Decreased lactate and potassium levels in natural moisturizing factor from the stratum corneum of mild atopic dermatitis patients are involved with the reduced hydration state. J Dermatol Sci. 2012 May;66(2):154-9. PMID 22464763.Tier 3Supports: The best available human evidence that lactate genuinely functions as a natural moisturising factor component rather than this being marketing shorthand. NMF components were extracted from three sequential tape-stripped stratum corneum samples from the volar forearm in healthy subjects and mild adult atopic dermatitis patients. RESULTS: "although FAAs levels were not remarkably reduced, levels of pyrrolidone carboxylic acid (PCA), lactate, urea, sodium and potassium were significantly decreased in NMF from mild AD skin. Among those components, only the topical application of potassium lactate effectively increased skin surface hydration indicating that reductions of lactate and potassium influence dry skin in mild AD patients." DISTRIBUTION FINDING with real mechanistic significance: "Unlike the distribution of filaggrin-derived FAAs and PCA, lactate, urea, potassium and sodium were abundant in the surface layer of the SC compared with the inner layer of the SC. Such findings strongly suggest that those components are supplied from outside the SC, i.e. they originate from sweat." So endogenous stratum corneum lactate is largely SWEAT-derived, not filaggrin-derived — a correction to the common teaching that NMF is simply a filaggrin breakdown product. SCOPE LIMITS: population is mild atopic dermatitis versus healthy controls, not photoageing or cosmetic dryness; sample size not stated in the abstract; the agent tested topically was potassium lactate, not free lactic acid at cosmetic pH.Funding / interest: COMMERCIAL INTEREST: lead author affiliated to the Innovative Beauty Science Laboratory, Kanebo Cosmetics Inc., Odawara, Japan — a cosmetics manufacturer with a direct interest in NMF-based moisturisation claims. Co-authors are from Tohoku University.
  11. Gloor M, Fluhr J, Lehmann L, Gehring W, Thieroff-Ekerdt R. Do urea/ammonium lactate combinations achieve better skin protection and hydration than either component alone? Skin Pharmacol Appl Skin Physiol. 2002 Jan-Feb;15(1):35-43. PMID 11803256.Tier 2Supports: An important CORRECTIVE to the assumption that lactic acid reliably hydrates as a standalone humectant. Twenty subjects with healthy skin, six randomised-order test areas on the forearms plus one untreated area, treated two weeks with: drug-free W/O vehicle; 5% ammonium lactate in W/O vehicle; 5% urea in W/O vehicle; 3% ammonium lactate + 3% urea; 5% ammonium lactate + 5% urea. Repetitive washings were added in the second week. Measures: TEWL, stratum corneum water content by corneometry (electrical capacitance), and cutaneous blood flow by laser Doppler, at baseline, day 7 and day 14. RESULT verbatim: "5% urea and both ammonium lactate/urea combinations produced significant stratum corneum hydration and improved stratum corneum barrier function; there were no significant differences between these three treatments." NOTE WHAT IS ABSENT: 5% ammonium lactate ALONE is conspicuously not among the treatments that achieved significant hydration and barrier improvement. This is a vehicle-controlled, within-subject, randomised-order design — methodologically stronger than most lactic acid cosmetic studies. SCOPE LIMITS: the agent is ammonium lactate (the neutralised salt), not free lactic acid at low pH; healthy skin, not xerotic or photoaged; two weeks only; n=20.Funding / interest: No conflict statement in the PubMed record. Author R. Thieroff-Ekerdt has an affiliation pattern consistent with pharmaceutical-industry involvement, and urea/ammonium lactate products are commercial; this could not be verified from the accessible record and is flagged rather than asserted.
  12. Usuki A, Ohashi A, Sato H, Ochiai Y, Ichihashi M, Funasaka Y. The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp Dermatol. 2003;12 Suppl 2:43-50. PMID 14756523.In vitroTier 3Supports: IN-VITRO ONLY — mouse B16 and human melanoma cell lines. NOT human skin, NOT patients. Glycolic acid or lactic acid at 300 or 500 microg/ml "inhibited melanin formation in similar dose-dependent manner, without affecting cell growth." Note the phrase 'similar dose-dependent manner' — the two acids behaved comparably; this paper does NOT show lactic acid is superior to glycolic acid on pigment. mRNA and protein expression and molecular size of tyrosinase, TRP-1 and TRP-2 were unaffected, but tyrosinase ACTIVITY was inhibited. Using human tyrosinase purified from the melanosome-rich large granule fraction, both acids "inhibit tyrosinase enzyme activity directly, but this effect was not due to the acidity of GA or LA, because adjusting the pH to 5.6 (the pH of GA and LA at concentrations of 2500 microg/ml), did not affect tyrosinase activity." Authors' careful framing: the acids "might work on pigmentary lesions not only by accelerating the turnover of the epidermis but also by directly inhibiting melanin formation in melanocytes." SCOPE LIMITS: melanoma cell lines are not normal melanocytes; concentrations are in-vitro culture doses with no established relationship to what reaches a melanocyte from a topical or peel application; the paper appears in a supplement issue. Any clinical depigmenting claim built on this is an inference, not a demonstrated human effect.Funding / interest: No conflict statement in the PubMed record. Kobe University Graduate School of Medicine academic authors. Supplement-issue publication; supplements are sometimes industry-sponsored, which could not be verified.
  13. Sarkar R, Lakhani R. Chemical Peels for Melasma: A Systematic Review. Dermatol Surg. 2024 Jul 1;50(7):656-661. PMID 38530985.Tier 1Supports: Systematic review of PubMed-indexed prospective case series of more than 10 cases and RCTs on chemical peels in melasma. Twenty-four studies included: 9 clinical/comparative trials and 15 RCTs, total sample size 1,075, study duration 8 to 36 weeks, only 8 split-face. All used self-assessment, physician global assessment and MASI. KEY CONCLUSION verbatim: "Glycolic acid was found to be the most safe and effective in melasma." Overall: "Chemical peels were found to be safe and effective in the management of melasma." CRITICAL SCOPE LIMIT stated by the authors: "A meta-analysis could not be done due to the heterogeneity of data" — so this is a narrative synthesis of the evidence base, and the ranking of glycolic acid as most safe and effective is a qualitative judgement, not a pooled quantitative estimate. Lactic acid is not singled out for a separate efficacy statement in the abstract.Funding / interest: No conflict statement in the accessible record. Lady Hardinge Medical College, New Delhi. Note: senior author Sarkar also authored the 2024 Dermatol Clin narrative review on the same topic, so these are not independent expert voices.
  14. Dorgham NA, Hegazy RA, Sharobim AK, Dorgham DA. Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: A systematic review and meta-analysis of comparative trials. J Cosmet Dermatol. 2020 Nov;19(11):2812-2819. PMID 32947652.Tier 1Supports: The best available quantitative synthesis specifically in DARKER SKIN TYPES — directly relevant to the higher-phototype question. Ten RCTs and three prospective comparative studies, 478 patients. POOLED ESTIMATES: glycolic acid favoured over trichloroacetic acid on MASI (mean difference -1.89, 95% CI -3.26 to -0.52, P = .007). Glycolic acid NOT favoured over tretinoin (MD 0.53, 95% CI -0.46 to 1.52, P = .3), vitamin C iontophoresis (MD 1.50, 95% CI -0.50 to 3.50, P = .14), or amino fruit acid (MD 0.39, 95% CI -0.64 to 1.42, P = .46). TCA favoured over topical hydroquinone (MD -5.30, 95% CI -6.41 to -4.19, P < .001) and Jessner's solution favoured over hydroquinone (MD -3.20, 95% CI -5.35 to -1.05, P = .004). CONCLUSION: "chemical peelings are effective as single agents for management of melasma in patients with darker skin types, with the use of topicals as maintenance treatment." HONEST NEGATIVE, ABOUT THE EVIDENCE: lactic acid does NOT appear in any of the pooled comparisons reported. Despite lactic acid being widely promoted as the peel of choice for darker skin, it did not enter the meta-analytic estimates in the one meta-analysis dedicated to darker skin. Jessner's solution — which contains 14% lactic acid — does appear, but its effect cannot be attributed to the lactic acid component given the co-formulated salicylic acid and resorcinol.Funding / interest: No conflict statement in the accessible record. Cairo University and National Research Center, Egypt.
  15. Kornhauser A, Coelho SG, Hearing VJ. Applications of hydroxy acids: classification, mechanisms, and photoactivity. Clin Cosmet Investig Dermatol. 2010 Nov 24;3:135-42. PMID 21437068; PMCID PMC3047947.Tier 4Supports: A NARRATIVE review (not systematic — tier 4) covering alpha-hydroxy, beta-hydroxy, polyhydroxy and bionic acids. Used here for two things, one positive and one negative. POSITIVE: on UV sensitivity it states "glycolic acid (10%) increased the SSR sensitivity of human skin, whereas SA (2%) did not", while noting "The photosensitizing effects of glycolic acid were small." It also relays the Usuki finding that "glycolic acid and lactic acid (300-500 microg/mL) suppressed melanin formation by directly inhibiting tyrosinase activity in human and mouse melanoma cells." NEGATIVE, and directly load-bearing for this entry: on reading the full text for molecular-weight-driven penetration, the review does NOT discuss how molecular weight or molecular size affects hydroxy acid skin penetration, and makes NO comparison between glycolic and lactic acid penetration. The only penetration mechanism it discusses is lipophilicity for a different compound: "betaLHA has an eight-carbon fatty chain linked to the benzene ring making it more lipophilic than SA. This may account for its slower skin penetration." The review also does not discuss lactic acid as an NMF component. The authors concede that despite the large literature, hydroxy acid "biological mechanism(s) of action still require more clarification", and emphasise "the important contribution of cosmetic vehicles in these types of studies".Funding / interest: Lead author Kornhauser is listed as "US Food and Drug Administration [retired]"; Coelho and Hearing are NIH. No commercial funding declared — one of the few genuinely non-industry sources in this package.
  16. Department of Health and Social Care. The licensing of non-surgical cosmetic procedures in England: consultation response. GOV.UK, updated 7 August 2025.Tier 1Supports: The authoritative statement of the England position, fetched and read directly. Over 11,800 consultation responses, majority agreeing with the proposals. The proposed model is a three-tier green/amber/red system: green = lower-risk, performable by non-healthcare professionals meeting training standards; amber = medium risk, requiring licensing plus oversight by a named regulated healthcare professional with an accredited qualification to prescribe, administer and supervise; red = highest risk, outside the licensing scheme and brought into CQC regulation. CRITICAL FOR ACCURACY: individual procedures have NOT been assigned to tiers. Verbatim: "further work is required to determine where specific procedures will sit in the proposed tiering system" and "initial work in this area will prioritise the introduction of regulations for the highest-risk procedures, and we will develop proposals which will be consulted on early next year." ON PEELS SPECIFICALLY: the consultation proposed that "laser and chemical peel procedures sit across different categories" based on strength and depth of penetration — a proposal only. STATUS: not in force; requires secondary legislation. Verbatim: "this work will be subject to further public consultations to inform a finalised design for the licensing scheme, which will be subject to Parliamentary debate before implementation." Chemical peels are otherwise mentioned only in satisfaction data. Some respondents argued there should be no amber category at all.
  17. Joint Council for Cosmetic Practitioners. Treatments (public information page), listing recognised procedural modalities and associated CPSA standards. Accessed 1 August 2026.Tier 4Supports: Establishes where chemical peels sit in UK voluntary regulation. The JCCP recognises exactly five procedural modalities: (1) Botulinum Toxins, (2) Dermal Fillers, (3) Skin Rejuvenation - Micro Needling and Peels, (4) Lasers and Light (LIPLED), (5) Hair Restoration Surgery. Chemical peels, including lactic acid peels, fall within modality 3, governed by the corresponding CPSA Standard. Practitioners must be "qualified at the appropriate educational level" for each modality they register for. SCOPE LIMITS, important for UK accuracy: the JCCP register is VOLUNTARY, not statutory — it carries no legal force and does not license anyone. The page gives no lactic-acid-specific concentration limits and no phototype-specific guidance. Separately reported: 689 registrants as at 1 January 2023, i.e. a small fraction of UK practitioners.

Continue learning with MSTA#

Skinipedia is written by the educators at MSTA, the medic-led skincare training academy in Liverpool.